Tekla Capital Management LLC Current Holdings: Foreign ADRs

Tekla Capital Management LLC current holdings: Foreign ADRs

Tekla Capital Management LLC reported $0.09 billion in depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), 6 positions, in its Form 13F for the quarter ended 2016-09-30; the largest are Shire plc, GlaxoSmithKline plc, AstraZeneca PLC.

Shire plc: Country of operation —; Class Sponsored ADR; Shares 231,413; Value $44,862,000.
GlaxoSmithKline plc: Country of operation —; Class Sponsored ADR; Shares 359,000; Value $15,484,000.
AstraZeneca PLC: Country of operation —; Class Sponsored ADR; Shares 463,800; Value $15,240,000.
Flamel Technologies SA: Country of operation —; Class Sponsored ADR; Shares 624,288; Value $7,741,000.

Form 13F-HR as filed (SEC CIK 1300336): quarter ended 2016-09-30, filed 2016-11-14. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.

Stock	Class	Shares	Value	Quarter end	Filed
Shire plc CUSIP 82481R106	Sponsored ADR	231,413	$44,862,000	2016-09-30	2016-11-14
GlaxoSmithKline plc CUSIP 37733W105	Sponsored ADR	359,000	$15,484,000	2016-09-30	2016-11-14
AstraZeneca PLC CUSIP 046353108	Sponsored ADR	463,800	$15,240,000	2016-09-30	2016-11-14
Flamel Technologies SA CUSIP 338488109	Sponsored ADR	624,288	$7,741,000	2016-09-30	2016-11-14
Forward Pharma A/S CUSIP 34986J105	Sponsored ADR	136,547	$2,867,000	2016-09-30	2016-11-14
DBV Technologies CUSIP 23306J101	Sponsored ADR	65,600	$2,383,000	2016-09-30	2016-11-14

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet